The Emmes Company LLC has been awarded a single award indefinite delivery contract by the Department of Health and Human Services' National Institutes of Health National Human Genome Research Institute to provide clinical research support and collaboration for various protocols. The potential value of the contract vehicle is $4 million with a period of performance through June 2026.
Under the contract, The Emmes Company has received four delivery orders to date for task areas supporting protocol monitoring, data management, regulatory submissions, statistical expertise, and data safety monitoring board functions. These orders are valued between $47,000 and $436,000 and will be performed over 7-12 month periods concluding in February 2024 in Potomac, Maryland. The original pre-solicitation notice sought clinical research support and collaboration services to advance the National Human Genome Research Institute's mission of analyzing genome structure and function, understanding genetic disease contributions, and accelerating genomic research application in public health.
The delivery orders awarded on the indefinite delivery contract represent the first tasks issued by the National Human Genome Research Institute to obtain specialized clinical research and statistical services in key areas like protocol development, regulatory compliance, data analysis, and safety oversight through June 2026.
Generated 1/5/24, 2:14 AM